Gut bacteria may tame antipsychotic side effects in schizophrenia
NCT ID NCT07371325
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a probiotic supplement (Pediococcus acidilactici) could reduce metabolic problems like high cholesterol and blood sugar caused by antipsychotic drugs. 36 adults with first-episode psychosis or schizophrenia took the probiotic or a placebo alongside their regular medication. The goal was to see if the probiotic could improve heart health markers without changing the psychiatric treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC ABNORMALITIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Navarrabiomed
Pamplona, Navarre, 31012, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Role-Play with a simulated patient: a new way to train nurses in mental health?
- Calm in a room: can sensory therapy soothe the mind?
- Spotting psychosis early could change lives — a major study tests whether faster treatment leads to better recovery
- Glucose monitors may guide teens away from diabetes
- Generic cariprazine put to the test: will it match the brand?